PGEN

PRECIGEN INC

CUSIP: 74017N105

Market Cap
-
Sector
Healthcare
Institutional Owners
0
Institutional Value
-

About

Precigen Inc. is a biotechnology company focused on developing gene and cell therapies to address unmet medical needs in oncology, immunology, and other therapeutic areas. The company utilizes its proprietary synthetic biology platforms to create novel treatments, including personalized cancer vaccines and off-the-shelf cellular therapies. Operating within the pharmaceutical preparations industry, Precigen aims to translate advanced genomic technologies into clinical solutions.

Institutional Holders

Loading...